ImmunityBio, Inc.IBRXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank42
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-223.56M
Near historical average
Percentile
P42
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-219.55M
Historical baseline
PeriodValueYoY Change
TTM$-223.56M+15.5%
2024$-264.43M+44.8%
2023$-478.66M-36.0%
2022$-351.88M-9.7%
2021$-320.75M-57.1%
2020$-204.22M-259.2%
2019$-56.85M+34.5%
2018$-86.74M+4.4%
2017$-90.73M+22.9%
2016$-117.71M-